Strengthening translational preclinical research through confirmatory multi-laboratory studies

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Sophia C. Rotter - , Berlin Institute of Health at Charité (Author)
  • María Arroyo-Araujo - , Berlin Institute of Health at Charité (Author)
  • Natascha I. Drude - , Berlin Institute of Health at Charité (Author)
  • Pasquale Pellegrini - , Berlin Institute of Health at Charité (Author)
  • Sebastian Kobold - , Ludwig Maximilian University of Munich, Helmholtz Zentrum München - German Research Center for Environmental Health (Author)
  • Günther H.S. Richter - , Charité – Universitätsmedizin Berlin (Author)
  • Oliver J. Müller - , University Hospital Schleswig-Holstein Campus Kiel, Deutsches Zentrum für Herz-Kreislaufforschung (DZHK) (Author)
  • Dunja Bruder - , Otto von Guericke University Magdeburg, Helmholtz Centre for Infection Research (Author)
  • Lars B. Riecken - , Leibniz Institute on Aging - Fritz Lipmann Institute (Author)
  • Björn Gerlach - , Central Institute of Mental Health (CIMH), Guarantors of EQIPD e.V., PAASP GmbH (Author)
  • Lena Schuler - , Technical University of Munich (Author)
  • Juliane Salbach-Hirsch - , Department of Internal Medicine III (Author)
  • Iman Dalloul - , Ludwig Maximilian University of Munich (Author)
  • Sebastian Kühn - , Leibniz Institute of Polymer Research Dresden (Author)
  • Juliane C. Wilcke - , Ludwig Maximilian University of Munich (Author)
  • Ulf Toelch - , Berlin Institute of Health at Charité (Author)

Abstract

Successful translation of promising preclinical findings into clinical application remains challenging. To address the rising concerns of failing clinical trials and the resulting economic, social, and ethical consequences, preclinical confirmatory studies have been proposed to generate sufficiently robust evidence for guiding the decision-making process. In a unique funding call, 17 studies in Germany aimed to confirm exploratory findings across various biomedical research fields in a rigorously planned and executed multi-laboratory set-up. Alongside these preclinical research projects, a meta-research project was funded to provide methodological support and collectively investigate confirmatory study design and experimental outcomes. After the first four-year funding period, an in-person workshop brought together representatives from the preclinical confirmatory studies to discuss lessons learned. We summarize the outcomes of these stakeholder discussions, highlight common pitfalls, and propose optimization strategies for experimental set-up and project coordination. As a result, we advocate for new roles—such as preclinical research coordinators—and improved rules and regulations in preclinical research to facilitate large-scale academic research projects. Moreover, we highlight that diverse stakeholders must collaborate to effectively integrate confirmatory multi-laboratory studies into the preclinical research ecosystem.

Details

Original languageEnglish
Article number1715361
JournalFrontiers in medicine
Volume12
Publication statusPublished - 2025
Peer-reviewedYes

External IDs

ORCID /0000-0001-7097-9953/work/224858712
PubMed 41574368

Keywords

ASJC Scopus subject areas

Keywords

  • confirmatory studies, experimental design, multi-laboratory trials, preclinical research, reproducibility, stakeholder engagement